What is it?
Our experimental autologous cancer vaccine is a personalized treatment created from the patient's deactivated tumor cells. Treatments like these work to activate the immune system against specific tumor-associated antigens found on the outside surface of the tumor cells that are different than normal 'self' cells.
With over 10 years of supporting pre-clinical research, our treatment is a whole cell tissue vaccine. Treatments like these allow for a variety of tumor associated antigens to be presented to the immune system. By utilizing a portion of the animal's own tumor tissue, we create a personalized treatment specific to the individual animal's cancerous cells. See the publications referenced on Our Technology page for information and discussion on multiple antigenic targets included in tissue vaccines and their impact on the overall likelihood of a successful response
Why Use it?
By utilizing a portion of the animal's own tumor tissue, we create a personalized treatment specific to the individual animal.
Whole-cell tissue vaccines contain the necessary components to potentiate an immune response against multiple cancer types that publications have noted to have immunogenic properties. This has been shown in preclinical studies for the our experimental autologous cancer vaccine.
Compared to other options available to veterinarians, our experimental autologous cancer vaccine is considerably more affordable.
As Easy as 1-2-3
The experimental autologous cancer vaccine treatment protocol involves three, 1mL subcutaneous administrations given one-week apart. The injection should be administered near the closest peripheral lymph node of tumor excision. The treatment should be stored refrigerated and may appear cloudy.
Excise the tumor and send it to our lab using our pre-paid overnight shipping service
We prepare the personalized vaccine and send it back to your clinic within 72 hours via overnight shipping
Administer the personalized treatment by subcutaneous injection weekly for 3 weeks
What are the Eligibility Criteria?
experimental autologous cancer vaccine can be used if:
Pathology has confirmed cancer diagnosis
Tumor has the ability to be surgically excised
The ideal sample is collected from the margin of the tumor, to include pseudocapsule and non-necrotic tumor tissue, 2-5gm (1-5cc) are utilized to create the treatment
- Cancer has been diagnosed as one of the following:
- Anal Sac Adenocarcinoma
Basal Cell Carcinoma
Mast Cell Tumors
Soft Tissue Sarcoma
Squamous Cell Carcinoma
Transitional Cell Carcinoma
experimental autologous cancer vaccine should NOT be considered if:
Tumor cannot be surgically excised
Tumor shows severe necrotic activity, excessive amounts of exudate or clinical signs of infection or cellulitis.
History of blood disorders
- Allergies to any of the following:
- Pig or porcine product
- Current medical treatments/prescriptions
- Anticoagulation medications
Prednisone or Steroids (if not off for at least 14 days)